Scott Bruder, MD, PhD

Bruder Consulting International, LLC New York, NY

Scott P. Bruder, MD, PhD, is an insightful and energetic healthcare leader with a 25-plus year history of bridging basic science, clinical medicine, and industrial development expertise to deliver innovative, commercially successful products that improve patients’ lives around the world. As a veteran Physician-Scientist Executive, he now leads Bruder Consulting International, providing a variety of services to medical device, regenerative medicine and biotechnology companies, as well as venture capital and private equity firms. Currently, he also serves as Chairman of the Board of Directors of Amendia, a leading provider of medical device and biologic implants for spinal surgery.

Dr. Bruder has a long and proven track record of performance across multiple roles in his career, and is an accomplished researcher and innovator with more than 20 issued and pending U.S. and international patents. He has published nearly 150 original articles, book chapters and abstracts in peer-reviewed journals, and received numerous awards including those from the American Institute of Medical and Biological Engineering, the American Academy of Orthopaedic Surgeons and the Orthopaedic Research Society.

Previously, Scott served as the Chief Medical and Scientific Officer of Stryker Corporation, where he guided clinical, scientific, innovation and IP strategic efforts across the company. Previously he was the Chief Science and Technology Officer at Becton, Dickinson and Company. Scott also served in a variety of senior executive and scientific roles, at Johnson & Johnson, Anika Therapeutics, and Osiris Therapeutics.

Dr. Bruder is a magna cum laude graduate from Brown University, and CWRU School of Medicine, where he also earned a PhD in stem cell biology before his clinical training at Albert Einstein Medical Center and the University of Pennsylvania.